1. Home
  2. Labeler Index
  3. Advanced Rx Of Tennessee, Llc
  4. 80425-0025
  5. Product Images: Pregabalin

Product Images Pregabalin

View Photos of Packaging, Labels & Appearance

Table of Contents

  1. Fig 1
  2. Fig 10
  3. Fig 11
  4. Fig 12
  5. Fig 2
  6. Fig 3
  7. Fig 4
  8. Fig 5
  9. Fig 6
  10. Fig 7
  11. Fig 9
  12. Formula
  13. Pregabalin 50 mg Cap Qty 30 80425 0025
  14. Pregabalin 50 mg Cap Qty 60 80425 0025
  15. Pregabalin 50 mg Cap Qty 90 80425 0025
  16. Structure

Product Label Images

The following 16 images provide visual information about the product associated with Pregabalin NDC 80425-0025 by Advanced Rx Of Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Fig 1

Fig 1

Fig 10

Fig 10

Fig 11

Fig 11

Fig 12

Fig 12

Fig 2

Fig 2

Fig 3

Fig 3

Fig 4

Fig 4

Percentage of patients who improved their pain from baseline after receiving Pregabalin 200mg three times a day, Pregabalin 100mg three times a day or a placebo is indicated by the text "Percentage Improvement In Pain from Baseline". However, the accuracy of the text is questionable due to errors.*

Fig 5

Fig 5

Fig 6

Fig 6

This appears to be a table or chart with information from multiple studies, measures, and doses of a drug compared to a placebo. It seems to indicate the percentage of patients in each study who had a certain outcome, but without any context or label for what that outcome is. The text also notes that some of the results were statistically significant compared to the placebo group. Without further information, it is not possible to provide a more specific or useful description.*

Fig 7

Fig 7

Fig 9

Fig 9

This appears to be a chart showing the percentage of patients who experienced improvement in pain levels when taking different doses of Pregabalin. There are four different dose levels shown: 100mg/day, 300mg/day, 450mg/day, and a placebo. The chart shows the percentage of patients who experienced improvement in pain levels in comparison to their baseline pain level.*

Formula

Formula

This text is a mathematical formula to estimate creatinine clearance (CLCr) in patients. The formula depends on the patient's age, weight and gender, as well as the level of creatinine in their serum. However, without additional context, it is unclear what purpose this formula serves or in what medical situations it might be used.*

Pregabalin 50 mg Cap Qty 30 80425 0025

Pregabalin 50 mg Cap Qty 30 80425 0025

Pregabalin 50 mg Cap Qty 60 80425 0025

Pregabalin 50 mg Cap Qty 60 80425 0025

Pregabalin 50 mg Cap Qty 90 80425 0025

Pregabalin 50 mg Cap Qty 90 80425 0025

Structure

Structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.